Incannex Healthcare Files 8-K on Director/Officer Changes
Ticker: IXHL · Form: 8-K · Filed: Oct 24, 2024 · CIK: 1873875
| Field | Detail |
|---|---|
| Company | Incannex Healthcare Inc. (IXHL) |
| Form Type | 8-K |
| Filed Date | Oct 24, 2024 |
| Risk Level | low |
| Pages | 3 |
| Reading Time | 3 min |
| Key Dollar Amounts | $0.0001, $375,000 |
| Sentiment | neutral |
Sentiment: neutral
Topics: corporate-governance, officer-changes, financials
TL;DR
Incannex Healthcare filed an 8-K detailing director/officer changes and financial exhibits.
AI Summary
Incannex Healthcare Inc. filed an 8-K on October 24, 2024, reporting on the departure of a director, election of new directors, appointment of officers, and compensatory arrangements. The filing also includes financial statements and exhibits, with the earliest event reported being October 21, 2024. The company is incorporated in Delaware and operates in the Pharmaceutical Preparations sector.
Why It Matters
Changes in board and officer composition can signal shifts in company strategy or governance, potentially impacting investor confidence and future performance.
Risk Assessment
Risk Level: low — This filing is primarily procedural, reporting on corporate governance and financial statements without announcing significant new risks or opportunities.
Key Players & Entities
- Incannex Healthcare Inc. (company) — Registrant
- October 21, 2024 (date) — Earliest event reported
- October 24, 2024 (date) — Filing date
- Delaware (jurisdiction) — State of Incorporation
- 2834 (industry_code) — Standard Industrial Classification
FAQ
Who departed from Incannex Healthcare's board or officer positions?
The filing indicates the departure of a director and the election of new directors, along with the appointment of certain officers, but specific names are not detailed in this summary.
What is the primary business of Incannex Healthcare Inc.?
Incannex Healthcare Inc. operates in the Pharmaceutical Preparations sector, with SIC code 2834.
When was the earliest event reported in this 8-K filing?
The earliest event reported in this filing was on October 21, 2024.
What is the company's state of incorporation?
Incannex Healthcare Inc. is incorporated in Delaware.
What items are covered by this 8-K filing?
This 8-K filing covers the departure of directors or certain officers, election of directors, appointment of certain officers, compensatory arrangements of certain officers, and financial statements and exhibits.
Filing Stats: 838 words · 3 min read · ~3 pages · Grade level 10.9 · Accepted 2024-10-24 07:01:37
Key Financial Figures
- $0.0001 — nge on which registered Common Stock, $0.0001 par value per share IXHL The Nasdaq
- $375,000 — o will receive an annual base salary of $375,000, a target annual incentive of up to 20%
Filing Documents
- ea0218506-8k_incannex.htm (8-K) — 30KB
- ea021850601ex10-1_incannex.htm (EX-10.1) — 28KB
- 0001213900-24-090121.txt ( ) — 239KB
- ixhl-20241021.xsd (EX-101.SCH) — 3KB
- ixhl-20241021_lab.xml (EX-101.LAB) — 33KB
- ixhl-20241021_pre.xml (EX-101.PRE) — 22KB
- ea0218506-8k_incannex_htm.xml (XML) — 4KB
01 Financial Statements and Exhibits
Item 9.01 Financial Statements and Exhibits. (d) Exhibits Exhibit No. Description 10.1*^ Employment Agreement, effective October 21, 2024, by and between the Company and Luigi M. Barbato, M.D. 104 Cover Page Interactive Data File (embedded within the Inline XBRL document) * Management Compensation Plan or Arrangement. ^ Certain schedules to this exhibit have been omitted pursuant to Item 601(a)(5) of Regulation S-K. Copies of the omitted schedules will be furnished to the SEC upon request. 2
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Incannex Healthcare Inc. Date: October 24, 2024 /s/ Joel Latham Name: Joel Latham Title: Chief Executive Officer and President 3